ThermoGenesis to distribute AXP AutoXpress system in China

05/13/2013 | Sacramento Bee (Calif.) (free registration), The

ThermoGenesis said it has received approval in China to distribute its AXP AutoXpress for the processing of stem cells from umbilical cord blood. "This is a major milestone for the company as a first mover in China for the automation of cord blood processing and presents a significant catalyst for the growth of our cord blood business," chief executive Matthew Plavan said.

View Full Article in:

Sacramento Bee (Calif.) (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL